Johnson & Johnson Receives FDA Approval for Imaavytm (Nipocalimab-Aahu), a New Fcrn Blocker Offering Long-Lasting Disease Control in the Broadest Population of People Living With Generalized Myasthenia Gravis (Gmg)

Yen Moves Higher Against Dollar After U.S. ADP Payroll Data, Last Down 0.3% at 142.82

Dollar Dips After U.S. ADP Payroll Data